Neurocrine Bio. (NBIX) PT Raised to $180 at RBC Capital

May 6, 2026 6:40 AM EDT Send to a Friend

RBC Capital analyst Brian Abrahams ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Neurocrine Bio. (NBIX) PT Raised to $180 at RBC Capital

Member Login

Free News Feed